The lawsuit also alleges the manufacturers knew of the link between the GLP-1 drugs and the risk of developing severe gastrointestinal issues, including gastroparesis. Gastroparesis, or stomach paralysis, slows or completely stops the movement of food from the stomach to the small intestine, preventing the stomach from properly emptyingneither drug lists gastroparesis as a potential side effect
This can lead to tiredness, weakness, and shakiness, as well as mood changes
Biochemistry 19 , 23212328 (1980)
Will you be able to switch to Retatrutide when it is available
There is no evidence that doses above 500mcg produce proportionally better results, and clinical trials using 1mg daily did not dramatically outperform lower doses
You can compare the options and costs on our pricing page